カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

抗生物質医薬品有効成分(API)の世界市場2022：ペニシリン系抗生物質、セファロスポリン系抗生物質、カルバペネム系抗生物質

◆英語タイトル：Global Antibiotics Active Pharmaceutical Ingredient (API) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO19140 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：118 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

抗生物質医薬品有効成分(API)市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の抗生物質医薬品有効成分(API)の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

抗生物質医薬品有効成分(API)市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ペニシリン系抗生物質、セファロスポリン系抗生物質、カルバペネム系抗生物質

用途別セグメントは次のように区分されます。
・製薬会社、受託製造機関（CMO）、受託開発・製造機関（CDMO）

世界の抗生物質医薬品有効成分(API)市場の主要な市場プレーヤーは以下のとおりです。
・Sandoz International、Centrient Pharmaceuticals、CordenPharma International、ACS DOBFAR、Nanjing Dorra Pharmaceutical Technology、DAEWOONG PHARMACEUTICAL、Parabolic Drugs、Penam Laboratories、ASIATIC DRUGS & PHARMACEUTICALS、Fresenius Kabi、The United Laboratories International Holdings、Aurobindo Pharma、Unimark Remedies、Savior Lifetec、Shenzhen Haibin Pharmaceutical、Sterile India、Zhejiang Jiuzhou Pharmaceutical、Kyongbo Pharm

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、抗生物質医薬品有効成分(API)製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗生物質医薬品有効成分(API)メーカーの企業概要、2019年～2022年までの抗生物質医薬品有効成分(API)の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗生物質医薬品有効成分(API)メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別抗生物質医薬品有効成分(API)の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの抗生物質医薬品有効成分(API)の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗生物質医薬品有効成分(API)市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および抗生物質医薬品有効成分(API)の産業チェーンを掲載しています。
・第13、14、15章では、抗生物質医薬品有効成分(API)の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 抗生物質医薬品有効成分(API)の概要
- 種類別分析（2017年vs2021年vs2028年）：ペニシリン系抗生物質、セファロスポリン系抗生物質、カルバペネム系抗生物質
- 用途別分析（2017年vs2021年vs2028年）：製薬会社、受託製造機関（CMO）、受託開発・製造機関（CDMO）
- 世界の抗生物質医薬品有効成分(API)市場規模・予測
- 世界の抗生物質医薬品有効成分(API)生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Sandoz International、Centrient Pharmaceuticals、CordenPharma International、ACS DOBFAR、Nanjing Dorra Pharmaceutical Technology、DAEWOONG PHARMACEUTICAL、Parabolic Drugs、Penam Laboratories、ASIATIC DRUGS & PHARMACEUTICALS、Fresenius Kabi、The United Laboratories International Holdings、Aurobindo Pharma、Unimark Remedies、Savior Lifetec、Shenzhen Haibin Pharmaceutical、Sterile India、Zhejiang Jiuzhou Pharmaceutical、Kyongbo Pharm
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ペニシリン系抗生物質、セファロスポリン系抗生物質、カルバペネム系抗生物質
・用途別分析2017年-2028年：製薬会社、受託製造機関（CMO）、受託開発・製造機関（CDMO）
・抗生物質医薬品有効成分(API)の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・抗生物質医薬品有効成分(API)のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・抗生物質医薬品有効成分(API)のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・抗生物質医薬品有効成分(API)の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・抗生物質医薬品有効成分(API)の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Antibiotics Active Pharmaceutical Ingredient (API) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antibiotics Active Pharmaceutical Ingredient (API) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pharmaceutical Companies accounting for % of the Antibiotics Active Pharmaceutical Ingredient (API) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Penicillin Antibiotics segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antibiotics Active Pharmaceutical Ingredient (API) include Sandoz International, Centrient Pharmaceuticals, CordenPharma International, ACS DOBFAR, and Nanjing Dorra Pharmaceutical Technology, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antibiotics Active Pharmaceutical Ingredient (API) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Penicillin Antibiotics
Cephalosporins
Carbapenem Antibiotics
Market segment by Application can be divided into
Pharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Contract Development & Manufacturing Organizations (CDMOs)
The key market players for global Antibiotics Active Pharmaceutical Ingredient (API) market are listed below:
Sandoz International
Centrient Pharmaceuticals
CordenPharma International
ACS DOBFAR
Nanjing Dorra Pharmaceutical Technology
DAEWOONG PHARMACEUTICAL
Parabolic Drugs
Penam Laboratories
ASIATIC DRUGS & PHARMACEUTICALS
Fresenius Kabi
The United Laboratories International Holdings
Aurobindo Pharma
Unimark Remedies
Savior Lifetec
Shenzhen Haibin Pharmaceutical
Sterile India
Zhejiang Jiuzhou Pharmaceutical
Kyongbo Pharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibiotics Active Pharmaceutical Ingredient (API) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibiotics Active Pharmaceutical Ingredient (API), with price, sales, revenue and global market share of Antibiotics Active Pharmaceutical Ingredient (API) from 2019 to 2022.
Chapter 3, the Antibiotics Active Pharmaceutical Ingredient (API) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibiotics Active Pharmaceutical Ingredient (API) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antibiotics Active Pharmaceutical Ingredient (API) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibiotics Active Pharmaceutical Ingredient (API).
Chapter 13, 14, and 15, to describe Antibiotics Active Pharmaceutical Ingredient (API) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Antibiotics Active Pharmaceutical Ingredient (API) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Penicillin Antibiotics
1.2.3 Cephalosporins
1.2.4 Carbapenem Antibiotics
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pharmaceutical Companies
1.3.3 Contract Manufacturing Organizations (CMOs)
1.3.4 Contract Development & Manufacturing Organizations (CDMOs)
1.4 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size & Forecast
1.4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume (2017-2028)
1.4.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Price (2017-2028)
1.5 Global Antibiotics Active Pharmaceutical Ingredient (API) Production Capacity Analysis
1.5.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Total Production Capacity (2017-2028)
1.5.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antibiotics Active Pharmaceutical Ingredient (API) Market Drivers
1.6.2 Antibiotics Active Pharmaceutical Ingredient (API) Market Restraints
1.6.3 Antibiotics Active Pharmaceutical Ingredient (API) Trends Analysis
2 Manufacturers Profiles
2.1 Sandoz International
2.1.1 Sandoz International Details
2.1.2 Sandoz International Major Business
2.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.1.4 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Centrient Pharmaceuticals
2.2.1 Centrient Pharmaceuticals Details
2.2.2 Centrient Pharmaceuticals Major Business
2.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.2.4 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CordenPharma International
2.3.1 CordenPharma International Details
2.3.2 CordenPharma International Major Business
2.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.3.4 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 ACS DOBFAR
2.4.1 ACS DOBFAR Details
2.4.2 ACS DOBFAR Major Business
2.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.4.4 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Nanjing Dorra Pharmaceutical Technology
2.5.1 Nanjing Dorra Pharmaceutical Technology Details
2.5.2 Nanjing Dorra Pharmaceutical Technology Major Business
2.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.5.4 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 DAEWOONG PHARMACEUTICAL
2.6.1 DAEWOONG PHARMACEUTICAL Details
2.6.2 DAEWOONG PHARMACEUTICAL Major Business
2.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.6.4 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Parabolic Drugs
2.7.1 Parabolic Drugs Details
2.7.2 Parabolic Drugs Major Business
2.7.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.7.4 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Penam Laboratories
2.8.1 Penam Laboratories Details
2.8.2 Penam Laboratories Major Business
2.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.8.4 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ASIATIC DRUGS & PHARMACEUTICALS
2.9.1 ASIATIC DRUGS & PHARMACEUTICALS Details
2.9.2 ASIATIC DRUGS & PHARMACEUTICALS Major Business
2.9.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.9.4 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Fresenius Kabi
2.10.1 Fresenius Kabi Details
2.10.2 Fresenius Kabi Major Business
2.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.10.4 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 The United Laboratories International Holdings
2.11.1 The United Laboratories International Holdings Details
2.11.2 The United Laboratories International Holdings Major Business
2.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.11.4 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Aurobindo Pharma
2.12.1 Aurobindo Pharma Details
2.12.2 Aurobindo Pharma Major Business
2.12.3 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.12.4 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Unimark Remedies
2.13.1 Unimark Remedies Details
2.13.2 Unimark Remedies Major Business
2.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.13.4 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Savior Lifetec
2.14.1 Savior Lifetec Details
2.14.2 Savior Lifetec Major Business
2.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.14.4 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Shenzhen Haibin Pharmaceutical
2.15.1 Shenzhen Haibin Pharmaceutical Details
2.15.2 Shenzhen Haibin Pharmaceutical Major Business
2.15.3 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.15.4 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Sterile India
2.16.1 Sterile India Details
2.16.2 Sterile India Major Business
2.16.3 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.16.4 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Zhejiang Jiuzhou Pharmaceutical
2.17.1 Zhejiang Jiuzhou Pharmaceutical Details
2.17.2 Zhejiang Jiuzhou Pharmaceutical Major Business
2.17.3 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.17.4 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Kyongbo Pharm
2.18.1 Kyongbo Pharm Details
2.18.2 Kyongbo Pharm Major Business
2.18.3 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product and Services
2.18.4 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antibiotics Active Pharmaceutical Ingredient (API) Breakdown Data by Manufacturer
3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antibiotics Active Pharmaceutical Ingredient (API)
3.4 Market Concentration Rate
3.4.1 Top 3 Antibiotics Active Pharmaceutical Ingredient (API) Manufacturer Market Share in 2021
3.4.2 Top 6 Antibiotics Active Pharmaceutical Ingredient (API) Manufacturer Market Share in 2021
3.5 Global Antibiotics Active Pharmaceutical Ingredient (API) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antibiotics Active Pharmaceutical Ingredient (API) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Region
4.1.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume by Region (2017-2028)
4.1.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2017-2028)
4.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue (2017-2028)
4.3 Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue (2017-2028)
4.4 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue (2017-2028)
4.5 South America Antibiotics Active Pharmaceutical Ingredient (API) Revenue (2017-2028)
4.6 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume by Type (2017-2028)
5.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Type (2017-2028)
5.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume by Application (2017-2028)
6.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Application (2017-2028)
6.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
7.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
7.3 North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
7.3.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2017-2028)
7.3.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
8.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
8.3 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
8.3.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2017-2028)
8.3.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
9.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
9.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Region
9.3.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
10.2 South America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
10.3 South America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
10.3.1 South America Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2017-2028)
10.3.2 South America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
11.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
11.3 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
11.3.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antibiotics Active Pharmaceutical Ingredient (API) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antibiotics Active Pharmaceutical Ingredient (API)
12.3 Antibiotics Active Pharmaceutical Ingredient (API) Production Process
12.4 Antibiotics Active Pharmaceutical Ingredient (API) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antibiotics Active Pharmaceutical Ingredient (API) Typical Distributors
13.3 Antibiotics Active Pharmaceutical Ingredient (API) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗生物質医薬品有効成分(API)の世界市場2022：ペニシリン系抗生物質、セファロスポリン系抗生物質、カルバペネム系抗生物質(Global Antibiotics Active Pharmaceutical Ingredient (API) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

抗生物質医薬品有効成分(API)の世界市場2022：ペニシリン系抗生物質、セファロスポリン系抗生物質、カルバペネム系抗生物質

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp